| Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging (NCT01815333) | M.D. Anderson Cancer Center | 2013-07-01 |
| Prospective Trial of Metformin - Chemoprevention Role (NCT01550900) | M.D. Anderson Cancer Center | 2013-07-01 |
| Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy (NCT01970254) | M.D. Anderson Cancer Center | 2013-06-24 |
| The Role of Lifestyle Factors in Breast Cancer-Related Outcomes (NCT02079662) | M.D. Anderson Cancer Center | 2013-06-13 |
| Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea (NCT01832402) | M.D. Anderson Cancer Center | 2013-06-11 |
| CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) (NCT01653717) | M.D. Anderson Cancer Center | 2013-06-11 |
| Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies (NCT01823198) | M.D. Anderson Cancer Center | 2013-06-11 |
| Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01729091) | M.D. Anderson Cancer Center | 2013-06-10 |
| Cervical Cancer Screening Study in Brazil (NCT02335372) | M.D. Anderson Cancer Center | 2013-06-01 |
| Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM) (NCT01782976) | M.D. Anderson Cancer Center | 2013-06-01 |
| Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT01427205) | M.D. Anderson Cancer Center | 2013-06-01 |
| An Endometrial Cancer Chemoprevention Study of Metformin (NCT01697566) | M.D. Anderson Cancer Center | 2013-05-30 |
| Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma (NCT01473628) | M.D. Anderson Cancer Center | 2013-05-20 |
| Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) (NCT01854554) | M.D. Anderson Cancer Center | 2013-05-17 |
| Three-Factor Eating Questionnaire in Measuring Eating Behavior in Adolescent and Young Adult Survivors of CNS Tumors (NCT01682824) | M.D. Anderson Cancer Center | 2013-05-17 |
| Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01664897) | M.D. Anderson Cancer Center | 2013-05-16 |
| Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix (NCT04723095) | M.D. Anderson Cancer Center | 2013-05-16 |
| NK Cells in Cord Blood Transplantation (NCT01619761) | M.D. Anderson Cancer Center | 2013-05-03 |
| An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin (NCT01816659) | M.D. Anderson Cancer Center | 2013-05-01 |
| Message: Study of Patients' Perception of Physician's Compassion (NCT02357108) | M.D. Anderson Cancer Center | 2013-05-01 |
| Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders (NCT00968461) | M.D. Anderson Cancer Center | 2013-05-01 |
| Testing Accountability in Patient Adherence (NCT01844557) | M.D. Anderson Cancer Center | 2013-05-01 |
| Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma (NCT01827111) | M.D. Anderson Cancer Center | 2013-04-25 |
| An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer (NCT05047965) | M.D. Anderson Cancer Center | 2013-04-25 |
| Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma (NCT01729104) | M.D. Anderson Cancer Center | 2013-04-25 |
| PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer (NCT01737619) | M.D. Anderson Cancer Center | 2013-04-03 |
| Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC) (NCT01821963) | M.D. Anderson Cancer Center | 2013-04-01 |
| Phase I/II Cabazitaxel for Recurrent Malignant Glioma (NCT01740570) | M.D. Anderson Cancer Center | 2013-04-01 |
| Ask Advise Connect (AAC) Harris Heath CPRIT (NCT01788787) | M.D. Anderson Cancer Center | 2013-04-01 |
| Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI) (NCT01539343) | M.D. Anderson Cancer Center | 2013-04-01 |
| Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy (NCT05134142) | M.D. Anderson Cancer Center | 2013-03-27 |
| Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma (NCT01793051) | M.D. Anderson Cancer Center | 2013-03-22 |
| Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) (NCT01751438) | M.D. Anderson Cancer Center | 2013-03-18 |
| Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT01787487) | M.D. Anderson Cancer Center | 2013-03-13 |
| Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies (NCT01630564) | M.D. Anderson Cancer Center | 2013-03-11 |
| IADAPT-Third Phase (NCT01698762) | M.D. Anderson Cancer Center | 2013-03-05 |
| Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia (NCT01319981) | M.D. Anderson Cancer Center | 2013-03-05 |
| Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload (NCT01508260) | M.D. Anderson Cancer Center | 2013-03-01 |
| Ipilimumab and Lenalidomide in Advanced Cancer (NCT01750983) | M.D. Anderson Cancer Center | 2013-03-01 |
| Dasatinib and Crizotinib in Advanced Cancer (NCT01744652) | M.D. Anderson Cancer Center | 2013-03-01 |
| Symptom Burden in Head and Neck Cancer (NCT01219673) | M.D. Anderson Cancer Center | 2013-03-01 |
| Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia (NCT01712308) | M.D. Anderson Cancer Center | 2013-02-21 |
| Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors (NCT01608152) | M.D. Anderson Cancer Center | 2013-02-20 |
| Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia (NCT01794702) | M.D. Anderson Cancer Center | 2013-02-20 |
| Ipilimumab and Imatinib Mesylate in Advanced Cancer (NCT01738139) | M.D. Anderson Cancer Center | 2013-02-19 |
| Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients (NCT01440582) | M.D. Anderson Cancer Center | 2013-02-18 |
| Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery (NCT01787500) | M.D. Anderson Cancer Center | 2013-02-15 |
| Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) (NCT01786343) | M.D. Anderson Cancer Center | 2013-02-05 |
| Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer (NCT01786265) | M.D. Anderson Cancer Center | 2013-02-05 |
| A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer (NCT01746043) | M.D. Anderson Cancer Center | 2013-02-01 |
| E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes (NCT01692197) | M.D. Anderson Cancer Center | 2013-02-01 |
| Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts (NCT00968396) | M.D. Anderson Cancer Center | 2013-02-01 |
| IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma (NCT01409174) | M.D. Anderson Cancer Center | 2013-02-01 |
| A Social Media Approach to Improve Genetic Risk Communication Phase I (NCT01645904) | M.D. Anderson Cancer Center | 2013-02-01 |
| CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL) (NCT01804335) | M.D. Anderson Cancer Center | 2013-02-01 |
| Technology and Navigation to Improve Survivorship Care (NCT01663870) | M.D. Anderson Cancer Center | 2013-02-01 |
| Minocycline Study in Pancreatic Cancer Patients (NCT01693523) | M.D. Anderson Cancer Center | 2013-01-28 |
| Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System (NCT01596127) | M.D. Anderson Cancer Center | 2013-01-24 |
| Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib (NCT01746836) | M.D. Anderson Cancer Center | 2013-01-17 |
| Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) (NCT01490723) | M.D. Anderson Cancer Center | 2013-01-01 |
| Dexamethasone Dyspnea Study (NCT01670097) | M.D. Anderson Cancer Center | 2013-01-01 |
| Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study (NCT01737671) | M.D. Anderson Cancer Center | 2012-12-27 |
| Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer (NCT01596140) | M.D. Anderson Cancer Center | 2012-12-18 |
| Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL (NCT01752426) | M.D. Anderson Cancer Center | 2012-12-17 |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells (NCT01362452) | M.D. Anderson Cancer Center | 2012-12-07 |
| Preventing Sexual Dysfunction With Aromatase Inhibitors (NCT01603303) | M.D. Anderson Cancer Center | 2012-12-05 |
| Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT01718743) | M.D. Anderson Cancer Center | 2012-12-03 |
| Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) (NCT01649622) | M.D. Anderson Cancer Center | 2012-12-01 |
| Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib (NCT01432119) | M.D. Anderson Cancer Center | 2012-12-01 |
| Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma (NCT01585194) | M.D. Anderson Cancer Center | 2012-11-29 |
| Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer (NCT01725165) | M.D. Anderson Cancer Center | 2012-11-28 |
| Allogeneic Stem Cell Transplant for CLL (NCT01629511) | M.D. Anderson Cancer Center | 2012-11-21 |
| Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT01636609) | M.D. Anderson Cancer Center | 2012-11-20 |
| Prediction of Recurrence Among Low Risk Endometrial Cancer Patients (NCT04604613) | M.D. Anderson Cancer Center | 2012-11-08 |
| Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer (NCT01709292) | M.D. Anderson Cancer Center | 2012-11-07 |
| Gene Expression in Hyperparathyroidism (NCT03044600) | M.D. Anderson Cancer Center | 2012-11-07 |
| Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk (NCT01720225) | M.D. Anderson Cancer Center | 2012-11-06 |
| TKI 258 in Von Hippel-Lindau Syndrome (VHL) (NCT01266070) | M.D. Anderson Cancer Center | 2012-11-01 |
| Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab (NCT01479179) | M.D. Anderson Cancer Center | 2012-11-01 |
| Doxycycline, Temozolomide and Ipilimumab in Melanoma (NCT01590082) | M.D. Anderson Cancer Center | 2012-11-01 |
| Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy (NCT00928161) | M.D. Anderson Cancer Center | 2012-11-01 |
| Trial of Curcumin in Cutaneous T-cell Lymphoma Patients (NCT00969085) | M.D. Anderson Cancer Center | 2012-11-01 |
| Study of Curcumin, Vorinostat, and Sorafenib (NCT01608139) | M.D. Anderson Cancer Center | 2012-11-01 |
| Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized Trial (NCT02151032) | M.D. Anderson Cancer Center | 2012-11-01 |
| Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas (NCT01730586) | M.D. Anderson Cancer Center | 2012-11-01 |
| Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina (NCT01703195) | M.D. Anderson Cancer Center | 2012-11-01 |
| CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies (NCT01664910) | M.D. Anderson Cancer Center | 2012-10-29 |
| Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT01590732) | M.D. Anderson Cancer Center | 2012-10-29 |
| Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy (NCT03023215) | M.D. Anderson Cancer Center | 2012-10-26 |
| Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma (NCT01701986) | M.D. Anderson Cancer Center | 2012-10-25 |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) (NCT01392183) | M.D. Anderson Cancer Center | 2012-10-24 |
| Domperidone in Treating Patients With Gastrointestinal Disorders (NCT01696734) | M.D. Anderson Cancer Center | 2012-10-23 |
| Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study (NCT01706705) | M.D. Anderson Cancer Center | 2012-10-22 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Neuropathic Pain in Head and Neck Cancer (NCT01846286) | M.D. Anderson Cancer Center | 2012-10-15 |
| Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) (NCT03053999) | M.D. Anderson Cancer Center | 2012-10-09 |
| Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema (NCT00951470) | M.D. Anderson Cancer Center | 2012-10-01 |
| Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients (NCT01269203) | M.D. Anderson Cancer Center | 2012-10-01 |
| Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men (NCT01447186) | M.D. Anderson Cancer Center | 2012-09-21 |
| Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer (NCT01629498) | M.D. Anderson Cancer Center | 2012-09-17 |